I, of course, am in favor of your seeing Dr. Wigley in the Scleroderma Center. There are not a lot of controlled trials of Enbrel or other TNF inhibitors in scleroderma. Many rheumatologists are successfully using the TNF inhibitors for the arthritis associated with scleroderma and mixed connective tissue disease to reduce pain and swelling. Unfortunately, I cannot comment specifically on your situation without seeing you.
About Alan Matsumoto, M.D.
Part-time Faculty, Division of Rheumatology
Johns Hopkins University